CPDD’s 2026 informational flyers and white papers are designed to clearly communicate key priorities in SUD and addiction science and policy. These resources provide an accessible overview of current research efforts, critical funding needs, particularly for NIDA, and the broader policy landscape impacting substance use prevention, treatment, and recovery. They also include key data points, legislative updates, and actionable steps to help stakeholders effectively engage with policymakers and advocate for evidence-based solutions to the ongoing opioid and substance use crises.
Return on Investment for Naloxone/Narcan
CPDD Cannabis Research Position Statement
CPDD Position Statement on Psychedelics
Return on Investment for Buprenorphine
Medications for Opioid Use Disorder (MOUD): Evidenced-Based Science and Practice